BLOOMINGTON, Ind.--(BUSINESS WIRE)--In a move reflecting the rapid acceptance of Cook Medical’s advanced endogaft for thoracic aortic aneurysm worldwide, the company has received approval to market the Zenith TX2® TAA Endovascular Graft in Canada. Globally, the Zenith TX2 Endovascular Graft is now available in more than 60 markets, including the United States, Canada, the United Kingdom, European Union, Australia and others internationally.
